Description
Chair : Maxime Mougeot
Mme
Carlotta Trigila
(University Paris Sud, IMNC)
29/05/2018 18:50
Talk
Targeted radionuclide therapy is the most used treatment modality against malign and benign diseases of thyroid. The large heterogeneity of therapeutic doses in patients and the range of effects observed state that an individualized dosimetry is essential for optimizing this therapy. The goal of the project is to strengthen the control of the doses delivered to thyroid during treatment of...
